Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
Código da empresaVVOS
Nome da EmpresaVivos Therapeutics Inc
Data de listagemDec 11, 2020
CEOMr. R. Kirk Huntsman
Número de funcionários109
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 11
Endereço7921 Southpark Plaza,
CidadeLITTLETON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal80120
Telefone18669084867
Sitehttps://vivos.com/
Código da empresaVVOS
Data de listagemDec 11, 2020
CEOMr. R. Kirk Huntsman
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados